公开(公告)号：EP2382987A1

公开(公告)日：2011-11-02

申请号：EP11156633.7

申请日：2007-03-23

申请人： Novartis Vaccines and Diagnostics GmbH

发明人： Scheffczik, Hanno

IPC分类号： A61K39/145 ,  A61K47/26 ,  A61P31/16 ,  C07K14/11

CPC分类号： A61K39/145 ,  A61K39/12 ,  A61K2039/5252 ,  A61K2039/55511 ,  A61K2039/70 ,  C07K14/005 ,  C12N2740/16222 ,  C12N2760/16134 ,  C12N2760/16234

摘要： Antigens from individual influenza virus strains are not refrigerated before being combined to make multivalent influenza virus vaccines. Moreover, influenza vaccines are not refrigerated between packaging and administration. Thus the need for refrigeration is minimized, and the cold-chain does not have to be maintained between vaccine manufacture and administration.

摘要翻译： 来自个别流感病毒株的抗原在组合以制备多价流感病毒疫苗之前不冷藏。 此外，流感疫苗在包装和给药之间不会冷藏。 因此，对制冷的需要被最小化，并且冷链不必在疫苗制造和给药之间保持。